Market Cap: $328.26M
Market Cap: $328.26M
Aperture, LLC Partners with QSI Consulting to Enhance Forensic Economic Services Aperture, LLC, a portfolio company of Genstar Capital, solidifies its commitment to expanding its forensic and litigati…
Quantum-Si Sets the Stage for Financial Transparency and Innovation in Proteomics Quantum-Si Incorporated, widely recognized as The Protein Sequencing Company™, is poised to unveil its financial resul…
Quantum-Si Showcases Innovations in Protein Sequencing at Festival of Genomics UK Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, is set to participate in the Festival of Genom…
Quantum-Si Showcases Innovations at Festival of Genomics UK Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, is set to make a significant impact at the upcoming Festival of Geno…
Quantum-Si Strengthens Workforce with New Inducement Equity Plan Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, announces the granting of 44,893 restricted stock units (RSUs)…
Quantum-Si Secures Funding for Proteomics Advancements Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, announces a substantial securities purchase agreement with institutional…
Quantum-Si's Strategic Talent Acquisition Initiative In a bid to bolster its workforce and drive innovation, Quantum-Si Incorporated, widely recognized as The Protein Sequencing Company™, announces th…
Quantum-Si Expands Global Footprint with New Distribution Partnerships Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, is making significant strides in the proteomics industry…
Quantum-Si Expands Global Reach to Transform Proteomics Landscape Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, makes a significant stride in expanding its international dist…
Quantum-Si and SkyWater Forge Path to Revolutionize Proteomics with Proteus™ Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, amplifies its commitment to transforming proteomic…
Quantum-Si Strengthens Workforce with New Equity Incentive Plan Grant Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, makes a significant move to enhance its talent pool by gra…
Quantum-Si Enhances Talent Pool with New Equity Incentives Quantum-Si Incorporated, recognized for its pioneering role in protein sequencing, takes a significant step in enhancing its workforce by gra…
Quantum-Si's Strategic Advancements in Proteomic Technology Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, makes significant strides in the field of proteomics with its latest…
QuantumSi's Strategic Engagement in Healthcare Conferences Quantum-Si Incorporated, a leader in the field of protein sequencing, is actively participating in two key investment conferences aimed at hi…
Quantum-Si Showcases Innovations at ASHG 2024 Annual Meeting Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, is set to make significant waves at the 2024 American Society of Hu…